Detalhe da pesquisa
1.
Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program.
Biol Blood Marrow Transplant
; 26(5): 978-984, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32035273